Associate Professor PURDUE UNIVERSITY WEST LAFAYETTE, Indiana, United States
Disclosure(s):
Andrea Pires dos Santos, DVM, MSc, PhD, DACVP (Clinical): No financial relationships to disclose
This section will discuss the role of microRNAs in the development of canine visceral hemangiosarcoma and their utility as biomarkers for the diagnosis and prognosis of this devastating disease. An overview of the challenges in diagnosing hemangiosarcoma in its early stages and predicting its behavior will be presented, as well as developments in the use of non-coding microRNAs as biomarkers of the disease. New diagnostic and prognostic tools are essential to assist veterinarians in diagnosing and stratifying patients according to their chances of survival, planning appropriate treatment, and communicating expectations with dog owners.
Learning Objectives:
Upon completion, participants will grasp the complexities involved in diagnosing visceral hemangiosarcoma.
Upon completion, participants will comprehend the limitations associated with grading systems in predicting the prognosis of canine visceral hemangiosarcoma.
Upon completion, participants will gain insight into recent advancements in microRNA-based biomarker development through research updates.
